Jon focuses on developing and executing worldwide patent strategies for life sciences and pharmaceutical companies. Jon concentrates on building patent portfolios to protect pharmaceutical products, which includes advising clients on portfolio creation and expansion, integrating patent and regulatory exclusivities, and advising on Orange Book listing strategies. He has a track record of success in identifying and executing strategies for late-stage inventions and navigating difficult patent issues. Notable patent portfolios Jon has worked on include Epidiolex, Copiktra, Farydak, Arikayce and Amrix.
Download full bio